ofloxacin has been researched along with beta-lactams in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.88) | 18.7374 |
| 1990's | 3 (8.82) | 18.2507 |
| 2000's | 22 (64.71) | 29.6817 |
| 2010's | 5 (14.71) | 24.3611 |
| 2020's | 2 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Guenounou, M; Miguères, ML; Ronco, E | 1 |
| Croize, J; Gout, JP; Le Noc, P; Robert, J | 1 |
| Chau, PY; Leung, YK; Lolekha, S; Ng, WS | 1 |
| Alperstein, P; France, K; Isenberg, HD | 1 |
| Hikida, M; Igarashi, A; Itahashi, K; Kitamura, M; Shiba, T | 1 |
| Bonner, D; Fung-Tomc, J; Gradelski, E; Kolek, B; Valera, L | 1 |
| Behra-Miellet, J; Dubreuil, L; Jumas-Bilak, E | 1 |
| Fujimoto, N; Iihara, K; Inatomi, H; Kobayashi, T; Matsumoto, T; Muratani, T; Nishimura, T; Takahashi, K; Yamada, Y | 1 |
| Gopal Rao, G; Mahankali Rao, CS; Starke, I | 1 |
| Odagiri, S; Shimada, J; Takahashi, H; Watanuki, Y | 1 |
| Burgess, DS; Hall, RG | 1 |
| Burgess, DS; Frei, CR; Moczygemba, LR | 1 |
| Bonfiglio, G; Lanzafame, A; Mattina, R; Santini, L | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L; Tocalli, L | 1 |
| Cottagnoud, M; Cottagnoud, P; Johnson, M; Piddock, L | 1 |
| Engel, AE; Glass, D; Li, C; Wexler, HM | 1 |
| Chen, WH; Hsueh, PR; Luh, KT | 1 |
| Krause, R; Laferl, H; Széll, M; Wenisch, C | 1 |
| Shinagawa, N; Takeyama, H; Taniguchi, M; Yura, J | 1 |
| Dimopoulos, G | 1 |
| De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L | 1 |
| May, T | 1 |
| Elias, N; Odeh, M; Sabetay, S; Sheikh-Ahmad, M; Slobodin, G; Weller, B; Zaygraikin, N | 1 |
| Coronel, P; del Prado, G; Díaz, C; García-Rodas, R; Gimeno, M; Gracia, M; Granizo, JJ; Huelves, L; Naves, PF; Ponte, MC; Rodríguez-Cerrato, V; Ruiz, V; Soriano, F | 1 |
| Basuino, L; Chambers, HF; Tattevin, P | 1 |
| Ermertcan, S; Hosgor-Limoncu, M; Tasli, H; Yurtman, AN | 1 |
| Gómez del Valle, C; Matía, M; Pérez-Calvo, JI; Torralba, MÁ | 1 |
| Salman, S; Van Sickels, JE; Young, M | 1 |
| Lam, JC; Lam, PK; Leung, HW; Martin, M; Minh, TB; Murphy, MB; Richardson, BJ; So, MK | 1 |
| Chiner, E; Ferrufino, E; Mejía, C; Ortiz de la Tabla, V | 1 |
| Azana, R; Boos, A; Conley, ME; Crawford, RI; Deans, GD; Hoang, L; Janz, L; Junker, A; Leo, SH; Morton, TL; Prendiville, J; Senger, C; Tilley, P; Turvey, SE | 1 |
| Nakagawa, Y; Sai, Y; Shimada, T; Suga, Y; Suzuki, T | 1 |
| Alfandari, S; Bajolet, O; Blanchard, H; Colomb-Cotinat, M; Daniau, C; Dumartin, C; Lecuru, M; Simon, L | 1 |
1 review(s) available for ofloxacin and beta-lactams
| Article | Year |
|---|---|
Successful approach to treatment of Helicobacter bilis infection in X-linked agammaglobulinemia.
Topics: Adolescent; Adult; Agammaglobulinemia; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Chronic Disease; Ertapenem; Genetic Diseases, X-Linked; Helicobacter; Helicobacter Infections; Humans; Male; Ofloxacin; Phylogeny; Treatment Outcome | 2012 |
3 trial(s) available for ofloxacin and beta-lactams
| Article | Year |
|---|---|
[Faropenem 300 mg 3 times daily versus levofloxacin 100 mg 3 times daily in the treatment of urinary tract infections in patients with neurogenic bladder and/or benign prostatic hypertrophy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactams; Drug Administration Schedule; Female; Humans; Lactams; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatic Hyperplasia; Urinary Bladder, Neurogenic; Urinary Tract Infections | 2002 |
Clostridium difficile-associated diarrhoea in patients with community-acquired lower respiratory infection being treated with levofloxacin compared with beta-lactam-based therapy.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Chi-Square Distribution; Clostridioides difficile; Community-Acquired Infections; Diarrhea; Female; Humans; Levofloxacin; Male; Ofloxacin; Prospective Studies; Respiratory Tract Infections | 2003 |
Moxifloxacin versus standard therapy in patients with pneumonia hospitalized after failure of preclinical anti-infective treatment.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Doxycycline; Drug Therapy, Combination; Female; Fluoroquinolones; Hospitalization; Humans; Levofloxacin; Macrolides; Male; Middle Aged; Moxifloxacin; Ofloxacin; Pneumonia, Bacterial; Quinolines; Treatment Failure | 2006 |
30 other study(ies) available for ofloxacin and beta-lactams
| Article | Year |
|---|---|
[In vitro activity of 4 fluoroquinolones against Klebsiella pneumoniae. Distribution according to phenotype resistance to aminoglycosides or beta-lactams].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; In Vitro Techniques; Klebsiella pneumoniae; Norfloxacin; Ofloxacin; Pefloxacin; Phenotype | 1990 |
[In vitro effect of various antibiotics: beta lactams, aminoglycosides and fluoroquinolones alone and in combination against P. aeruginosa isolated from patients with mucoviscidosis].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Ofloxacin; Pseudomonas aeruginosa | 1989 |
In vitro susceptibility of strains of Pseudomonas pseudomallei isolated in Thailand and Hong Kong to some newer beta-lactam antibiotics and quinolone derivatives.
Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Hong Kong; Humans; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Pseudomonas; Quinolines; Thailand | 1986 |
In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia.
Topics: Anti-Infective Agents; beta-Lactams; Burkholderia cepacia; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Pseudomonas aeruginosa; Xanthomonas | 1999 |
In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Carrier Proteins; Cefdinir; Cephalosporins; Dipeptidases; Drug Stability; Escherichia coli Proteins; Hexosyltransferases; Imipenem; Lactams; Levofloxacin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Ofloxacin; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding; Serine-Type D-Ala-D-Ala Carboxypeptidase; Thienamycins | 1999 |
Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; beta-Lactams; Enterobacteriaceae; Enterococcus faecalis; Fluoroquinolones; Indoles; Kinetics; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Staphylococcus aureus; Streptococcus; Vancomycin | 2001 |
Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams.
Topics: Anaerobiosis; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; beta-Lactams; Ciprofloxacin; Clindamycin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 2002 |
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chronic Disease; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Lactams; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2001 |
In vitro activity of parenteral Beta-lactams, levofloxacin and tobramycin alone or in combination against extended-spectrum Beta-lactamase producing Klebsiella pneumoniae.
Topics: beta-Lactamases; beta-Lactams; Drug Therapy, Combination; Infusions, Parenteral; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Tobramycin | 2004 |
Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Klebsiella pneumoniae; Lactams; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Ofloxacin; Thienamycins | 2004 |
In vitro activity of levofloxacin against recent Gram-negative nosocomial pathogens.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2005 |
Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Pneumococcal; Polymerase Chain Reaction; Respiratory Tract Infections; Streptococcus pneumoniae | 2005 |
In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pseudomonas aeruginosa | 2005 |
Preincubation of pneumococci with beta-lactams alone or combined with levofloxacin prevents quinolone-induced resistance without increasing intracellular levels of levofloxacin.
Topics: Anti-Infective Agents; beta-Lactams; Colony Count, Microbial; Culture Media; Drug Interactions; Drug Resistance, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Streptococcus pneumoniae | 2005 |
In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Humans; Imipenem; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Thienamycins | 2005 |
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Length of Stay; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Taiwan | 2005 |
[Bilophila wadsworthia isolated from surgical specimens].
Topics: Anti-Bacterial Agents; beta-Lactams; Bilophila; Ciprofloxacin; Clindamycin; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Humans; Japan; Levofloxacin; Minocycline; Ofloxacin; Peritonitis; Postoperative Complications; Specimen Handling; Surgical Wound Infection | 2006 |
Antibiotics selection for bacteremic pneumonia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Macrolides; Ofloxacin; Pneumonia, Bacterial; Treatment Outcome | 2007 |
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pneumonia; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
[New antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Ertapenem; Humans; Ketolides; Minocycline; Ofloxacin; Tigecycline; Virginiamycin | 2008 |
Levofloxacin-induced delirium.
Topics: Age Factors; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Brain; Clarithromycin; Confusion; Delirium; Ertapenem; Hallucinations; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia; Risk Factors; Sex Factors; Time Factors; Withholding Treatment | 2009 |
Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Child; Drug Resistance, Bacterial; Europe; Female; Humans; Levofloxacin; Macrolides; Male; Microbial Sensitivity Tests; Ofloxacin; Streptococcal Infections; Streptococcus pyogenes; Young Adult | 2009 |
Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated response.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Community-Acquired Infections; DNA Gyrase; DNA Mutational Analysis; DNA Transposable Elements; Fluoroquinolones; Gene Expression Profiling; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Ofloxacin; Penicillin-Binding Proteins; Selection, Genetic; SOS Response, Genetics; Staphylococcal Infections; Transcription Factors; Up-Regulation | 2009 |
Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Synergism; Drug Therapy, Combination; Ertapenem; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2008 |
[Treatment of community-acquired pneumonia in adults: ertapenem versus cefditoren?].
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Ertapenem; Humans; Ofloxacin; Pneumonia, Bacterial | 2010 |
Osteomyelitis after bilateral sagittal split osteotomy: case report and a review of the management.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Bone Plates; Bone Screws; Clindamycin; Drainage; Enterobacteriaceae Infections; Ertapenem; Female; Gram-Negative Bacterial Infections; Humans; Jaw Fixation Techniques; Mandible; Ofloxacin; Open Bite; Orthognathic Surgical Procedures; Osteomyelitis; Osteotomy; Osteotomy, Le Fort; Retrognathia; Streptococcal Infections | 2011 |
Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South China.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cephalexin; China; Chloramphenicol; Drug Utilization; Environmental Monitoring; Erythromycin; Fluoroquinolones; Hong Kong; Humans; Macrolides; Ofloxacin; Risk Assessment; Sewage; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Pollution, Chemical | 2012 |
Empyema caused by Legionella pneumophila.
Topics: Acute-Phase Proteins; Aged; Antigens, Bacterial; beta-Lactams; Body Fluids; Cough; Drug Therapy, Combination; Dyspnea; Empyema, Pleural; Humans; Legionella pneumophila; Legionnaires' Disease; Male; Ofloxacin; Tomography, X-Ray Computed | 2012 |
Examination of Aggregate Formation upon Simultaneous Dissolution of Methacrylic Acid Copolymer LD Enteric Coating Agent, Pharmaceutical Additives, and Zwitterionic Ingredients.
Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Liberation; Ofloxacin; Polymethacrylic Acids; Static Electricity; Sulfur Compounds; Tablets, Enteric-Coated; Tegafur | 2020 |
Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France.
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Cross Infection; Delivery of Health Care; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Nitrofurantoin; Ofloxacin; Penicillins; Urinary Tract Infections | 2022 |